Evidence map›Paper›PMID 39391545›Full record

ArticleCirculation reports2024

Usefulness of Native T1 in Cardiac Magnetic Resonance Imaging and Echocardiographic Strain Parameters for Detecting Early Cardiac Involvement in Fabry Cardiomyopathy.

Shoko Nakagawa, Masashi Amano, Yurie Tamai, Ayaka Mizumoto, Shinichi Kurashima, Yuki Irie, Kenji Moriuchi, Takahiro Sakamoto, Makoto Amaki, Hideaki Kanzaki and 3 more

Abstract read
In one paragraph

Article in Circulation reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Staging of Fabry cardiomyopathy in clinical practice: an algorithm proposal.International journal of cardiology. Heart & vasculature · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Shoko NakagawaDepartment of Heart Failure and Transplantation, National Cerebral and Cardiovascular Center Osaka Japan.
Masashi AmanoDepartment of Heart Failure and Transplantation, National Cerebral and Cardiovascular Center Osaka Japan.
Yurie TamaiDepartment of Clinical Laboratory, National Cerebral and Cardiovascular Center Osaka Japan.
Ayaka MizumotoDepartment of Clinical Laboratory, National Cerebral and Cardiovascular Center Osaka Japan.
Shinichi KurashimaDepartment of Heart Failure and Transplantation, National Cerebral and Cardiovascular Center Osaka Japan.
Yuki IrieDepartment of Heart Failure and Transplantation, National Cerebral and Cardiovascular Center Osaka Japan.
Kenji MoriuchiDepartment of Heart Failure and Transplantation, National Cerebral and Cardiovascular Center Osaka Japan.
Takahiro SakamotoDepartment of Heart Failure and Transplantation, National Cerebral and Cardiovascular Center Osaka Japan.
Makoto AmakiDepartment of Heart Failure and Transplantation, National Cerebral and Cardiovascular Center Osaka Japan.
Hideaki KanzakiDepartment of Heart Failure and Transplantation, National Cerebral and Cardiovascular Center Osaka Japan.
Yoshiaki MoritaDepartment of Radiology, National Cerebral and Cardiovascular Center Osaka Japan.
Takeshi KitaiDepartment of Heart Failure and Transplantation, National Cerebral and Cardiovascular Center Osaka Japan.
Chisato IzumiDepartment of Heart Failure and Transplantation, National Cerebral and Cardiovascular Center Osaka Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Non-invasive diagnosis of disease stage in Fabry cardiomyopathy with multimodality imaging is pivotal when deciding on the appropriate time to initiate enzyme replacement therapy. However, this approach has not been well established. Methods and Results: We enrolled 14 patients with Fabry disease. All patients were evaluated using echocardiography and contrast cardiac magnetic resonance (CMR), and were divided into either an early-stage group without left ventricular hypertrophy (LVH; wall thickness >12 mm) or late gadolinium enhancement (LGE; n=7; median age 37 years; 4 female), or an advanced-stage group with LVH and/or LGE (n=7; median age 66 years; 7 female). Strain data from echocardiography and T1 mapping on CMR were compared between the groups. In the advanced-stage group, all strain data were impaired. In the early-stage group, localized longitudinal strain in the basal posterolateral segment was already reduced but both localized and global circumferential strain remained preserved. On CMR analysis, global and localized native T1 shortening were observed in the early-stage group, but were pseudo-normalized in the advanced-stage group. In logistic regression analysis, localized circumferential strain had significant diagnostic value for differentiating between early- and advanced stage (P=0.037) and significantly improved the predictive power of the model containing localized native T1 in CMR. Conclusions: A combination of localized native T1 in CMR and echocardiographic strain parameters could be useful for staging Fabry cardiomyopathy.

Indexed as

Cardiac magnetic resonanceCombination diagnosisEchocardiographic strain parametersFabry cardiomyopathyNative T1

Identifiers

PMID39391545
PMCPMC11464016

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.